White Gold Corp. Identifies New District Scale High Grade Gold Trends on and Contiguous to Vertigo Discovery, JP Ross Property

V.WGO, White Gold, gold, Yukon

White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company”) is pleased to announce it has identified multiple new high-grade gold mineralization trends across its JP Ross property further adding to the Company’s pipeline of regional gold discoveries. The new trends were identified on the Stage Fright, Sabotage, Topaz, and Vertigo targets, all located within 10 km of the Vertigo Discovery. Several additional targets have also been identified on the JP Ross and will be tested in due course. Highlights to date include multiple bedrock samples from trace to 4.65 g/t Au and multiple surface samples from trace to 94.4 g/t Au. These newly discovered mineralized zones were identified using the innovative GT Probe, a proprietary device enabling fast and cost-efficient direct bedrock sampling. These are the first results from the Company’s $13 million fully funded 2019 exploration program, backed by partners Agnico Eagle Mines Limited (TSX: AEM, NYSE: AEM) and Kinross Gold Corp (TSX: K, NYSE: KGC). The 2019 program includes 17,000 metres of diamond drilling which is underway on the Vertigo target (JP Ross property), Golden Saddle & Arc deposits (White Gold property) and QV property, Yukon Canada. read more

Goldplay’s Nava Gold Discovery Continues to Grow as New Surface Continuous Channel Sampling Returns Wide Gold Intersection of 24 m at 2.1 g/t Au, Including 5 m @ 4.0 g/t Au

V.GPLY, Goldplay Exploration, gold
Figure 1 Nava – Location to the west of the San Marcial Resource and the Faisanes Target (CNW Group/Goldplay Exploration Ltd)

Goldplay Exploration Ltd. (TSXV: GPLYFRANKFURT: GPE, OTCQB: GLYXF) (“Goldplay” or the “Company”) is pleased to announce that a broad high grade gold (Au) zone has been encountered, on surface, at the Nava Target, 300 m along strike, west of the original gold bearing Nava trenches at the San Marcial Project, Sinaloa, Mexico, as recently announced (see News Release dated 16 April 2019). read more

NexGen Continues to Intersect High-Grade Mineralization in all A2 and A3 Targets Highlighting Strength of Continuity at Arrow

T.NXE, NexGen, uranium
Figure 1: Arrow Deposit Drill Hole Locations (CNW Group/NexGen Energy Ltd.)

 NexGen Energy Ltd. (“NexGen” or the “Company”) (TSX: NXE, NYSE MKT: NXE) is pleased to report radioactivity results for an additional forty holes comprising 18,166.5 m from the Company’s Feasibility stage drilling program at our 100% owned, Rook I property in the Athabasca Basin, Saskatchewan. read more

Aben Resources Announces the Commencement of Diamond Drilling at the Forrest Kerr Gold Project in BC’s Golden Triangle and the Completion of Drilling at the Justin Gold Project in the Yukon

Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Aben or the Company”) announces the commencement of diamond drilling at the Forrest Kerr Gold Project in BC’s Golden Triangle and the completion of the 2019 drill program at the Justin Gold Project in the Yukon. The Company is planning to start with another 5000-meter drill program at Forrest Kerr this year that can be expanded to 10,000 meters as results dictate. Aben Resources is well funded with over $5 million in the treasury. read more

Victoria Gold: Edging Up to First Gold Pour

Victoria Gold, V.VIT, gold, Yukon

Almost exactly two years ago I was on the Yukon Mining Alliance Media Tour and went to the Victoria Gold (V.VIT) Dublin Gulch Eagle Mine project, 80 bumpy kilometres from Mayo, Yukon. There, VP Exploration, Paul Gray took us on a tour of the proposed mine site. There were some roads bulldozed out of the bush, drill collars, a large camp which was somewhat empty and a vision. John McConnell’s vision of a 200,000 ounce per year gold mine. read more

FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals

SD acquires platform company to advance R&D of targeted application of micro-Palmitoylethanolamide impacting the human endocannabinoid system
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company (the “Parties”), announced today that, on June 28, 2019, they finalized the acquisition by FSD Pharma of all of the issued and outstanding securities of Prismic (the “Transaction”). Pursuant to the terms of a previously-announced securities exchange Agreement, FSD Pharma has acquired all outstanding common and preferred shares of Prismic for an aggregate purchase price of approximately US$17.5 million (CAD$23.4 million based on an exchange rate of US$1 to CAD$1.3349), satisfied by the issuance of approximately 102.7 million Class B subordinate voting shares in the capital of FSD Pharma (each, an “FSD Share”) at a deemed price of CAD$0.2275 (US$0.1704) per FSD Share. In addition, FSD Pharma has agreed to assume approximately US$3.05 million of outstanding Prismic long- and short-term liabilities. All of the outstanding Prismic stock options and warrants have been converted into options and warrants to purchase FSD shares, with the number and exercise price of such securities having been adjusted in accordance with the exchange ratio under the Agreement. read more